UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of November 2026
Commission
File Number: 001-41657
CBL
INTERNATIONAL LIMITED
(Exact
Name of Registrant as Specified in its Charter)
Level
23-2, Menara Permata Sapura
Kuala
Lumpur City Centre
50088
Kuala Lumpur
Malaysia
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Change
in Registrant’s Certifying Accountant
On
November 13, 2026, CBL International Limited (the “Company”) appointed Privatco CPA Limited (“Privatco”) as its
independent registered public accounting firm and dismissed MRI Moores Rowland LLP (“MRI”) as its independent registered
public accounting firm, effective immediately. The appointment of Privatco was made after a careful evaluation process undertaken by
the Company and was approved by the audit committee of the board of directors of the Company.
The
audit reports of MRI on the consolidated financial statements of the Company as of and for the fiscal years ended December 31, 2025 and
2024 did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or
accounting principles.
In
connection with the audits of the Company’s consolidated financial statements for the fiscal years ended December 31, 2025 and
2024, and in the subsequent interim period through the date of this report, there were no disagreements (as that term is used in Item
16F(a)(1)(iv) of Form 20-F) with MRI on any matters of accounting principles or practices, financial statement disclosure or auditing
scope and procedures which, if not resolved to the satisfaction of MRI, would have caused MRI to make reference to such matters in its
audit reports. MRI has not conducted an audit of the Company’s internal control over financial reporting. There were no reportable
events (as that term is described in Item 16F(a)(1)(v) of Form 20-F) during the fiscal years ended December 31, 2025 and 2024, or in
the subsequent interim period through the date of this report.
During
the fiscal years ended December 31, 2025 and 2024, and in the subsequent interim period through the date of this report, neither the
Company nor anyone on its behalf consulted Privatco regarding any of the matters or events set forth in Item 16F(a)(2)(i) and (ii) of
Form 20-F.
In
accordance with Item 16F(a)(3) of Form 20-F, the Company provided MRI with a copy of the foregoing disclosure and requested MRI to furnish
the Company with a letter addressed to the Securities and Exchange Commission stating whether or not MRI agrees with the above statements.
A copy of MRI’s letter, dated November 11, 2026, is filed as Exhibit 99.1 to this report on Form 6-K.
Incorporation
By Reference
This
current report on Form 6-K is hereby incorporated by reference into the registration statement of CBL International Limited on Form F-3
(File No. 333-284228), to be a part thereof from the date on which this current report on Form 6-K is submitted and to the extent not
superseded by documents or reports subsequently filed or furnished.
Exhibit
Index
| Exhibit
No. |
|
Description |
| 99.1 |
|
Letter of MRI Moores Rowland LLP to the U.S. Securities and Exchange Commission dated November 11, 2026 |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
CBL
International Limited |
| |
|
|
| Date:
November 16, 2026 |
By: |
/s/
Teck Lim Chia |
| |
|
Teck
Lim Chia |
| |
|
Chief
Executive Officer |
Exhibit
99.1

Chartered
Accountants
November
11, 2026
Securities
and Exchange Commission
100 F Street, N.E.
Washington,
DC 20549
Commissioners:
MRI
Moores Rowland LLP (“MRI”) has been furnished with a copy of the Form 6-K to be filed by CBL International Limited (the “Company”)
on November 11, 2026. MRI does not disagree with the Company’s statements regarding MRI contained in the Form 6-K filing.
MRI
has no basis to agree or disagree with other statements of the Company contained therein.
| Very truly yours, |
|
| |
|
|
| /s/
MRI Moores Rowland LLP |
|
| Name: |
Tsang Siu For Thomas |
|
| Title: |
Audit Engagement Partner |
|
| MRI Moores Rowland LLP |
|
MRI Moores Rowland LLP (T14LL1146H)
72 Anson Road #07-04 Anson House, Singapore 079911
Web www.mooresrowland.sg Tel + 65 6221 6116 |
 |